Policy UpdatesMedicare AdvantageNovember 27, 2024

Carelon Medical Benefits Management, Inc. updates

Effective March 23, 2025

Effective on March 23, 2025, the following Carelon Medical Benefits Management, Inc. Clinical Appropriateness Guideline updates will be adopted for Anthem. This article is to communicate the plan adoption of these Carelon Medical Benefits Management, Inc. guidelines. Existing prior authorization requirements have not changed. In the event a prior authorization requirement for these services will be implemented, a separate notice will be distributed before the addition of any prior authorization requirements.

The following guideline updates have a publish date of March 23, 2025:

  • Genetic Testing
    • Carrier Screening in the Reproductive Setting
    • Genetic Testing for Inherited Conditions
    • Hereditary Cancer Testing
  • Radiology
    • Imaging of the Abdomen and Pelvis
    • Imaging of the Chest
    • Oncologic Imaging
  • Radiation Oncology
    • Perirectal Hydrogel Spacer for Prostate Radiotherapy
    • Proton Beam Therapy
    • Radiation Therapy (excludes Proton)

You may access and download a copy of the current and upcoming guidelines here.

Please share this notice with other members of your practice and office staff.

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

NVBCBS-CR-074089-24-CPN73647

PUBLICATIONS: January 2025 Provider Newsletter